When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
MBIO - Mustang Bio top gainer in market on positive gene therapy data in rare immune disorder
Mustang Bio Inc.
Thinly traded micro cap Mustang Bio (MBIO+124.1%) is up on a whopping 420x surge in volume in reaction to positive results from a Phase 1/2 clinical trial evaluating a lentiviral gene therapy in infants with an ultra-rare inherited disorder called XSCID characterized by the absence of or dysfunctional immune cells. The lack of immunity is usually fatal due to severe infections. The company will develop the candidate as MB-107.
More news on: Mustang Bio, Inc., Healthcare stocks news, Stocks on the move,